QUINOLINE COMPOUND AND USE THEREOF - META PHARMACEUTICAL HK LTD

Title:

QUINOLINE COMPOUND AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/138675

Kind Code:

A1

Abstract:

Provided are a quinoline derivative represented by formula (I) that can be used as a lactate dehydrogenase inhibitor, a pharmaceutical composition thereof, a preparation method therefor, and a use thereof.

Inventors:

XU KE (CN)
XIANYU ANJIN (CN)
LI DEYAO (CN)
WU XIAOXING (CN)
PAN WEI (CN)
ZHOU SHIQIANG (CN)

Application Number:

PCT/CN2023/073268

Publication Date:

July 27, 2023

Filing Date:

January 19, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

META PHARMACEUTICAL HK LTD (CN)

International Classes:

A61K31/4706; C07D401/04; A61P35/00; A61P37/00; C07D401/14; C07D405/14

Domestic Patent References:

WO2013096153A1	2013-06-27
WO2013096151A1	2013-06-27

Foreign References:

US20130225524A1

2013-08-29

Attorney, Agent or Firm:

BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: N-HYDROXYQUINOLINE CARBOXAMIDE COMPOUND AND USE THEREOF

Next Patent: TRICYCLIC FUSED HETEROCYCLIC PDE3/4 DUAL INHIBITOR AND USE THEREOF